Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,000 shares at $382.83 ($383K) on 2020-02-07, disclosed to the SEC on 2020-02-10.
Open-market sale of $383k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |